Literature DB >> 31025676

Isodunnianol alleviates doxorubicin-induced myocardial injury by activating protective autophagy.

Can Chen1, Li Jiang, Min Zhang, Xiaoli Pan, Cheng Peng, Wei Huang, Qinglin Jiang.   

Abstract

Recurrent cardiotoxicity limits the clinical application of doxorubicin (DOX); however the detailed molecular mechanism of DOX cardiotoxicity remains unclear. In the current study, we found that a natural product extracted from Illicium verum, isodunnianol (IDN), mitigates DOX-induced cardiotoxicity by regulating autophagy and apoptosis both in vitro and in vivo. DOX suppressed protective autophagy and induced apoptosis in H9C2 cardiac myoblasts. Additionally, IDN demonstrated up-regulated autophagy and reduced apoptosis through the activation of the AMPK-ULK1 pathway. In addition, the beneficial effects of IDN on DOX which induced myocardial injury were dependent on AMPK and ULK1 phosphorylation. Similar results were also observed in a DOX-induced cardiotoxicity rat model. The combination of IDN and DOX resulted in decreased apoptosis and inflammatory myocardial fibrosis compared to the DOX mono-treatment group. In summary, our findings provide novel insights into the prevention of DOX-related toxicity by isodunnianol, a food source natural product, warranting further investigation.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31025676     DOI: 10.1039/c9fo00063a

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  8 in total

Review 1.  Molecular mechanisms of doxorubicin-induced cardiotoxicity: novel roles of sirtuin 1-mediated signaling pathways.

Authors:  Jie Wang A; Jingjing Zhang; Mengjie Xiao; Shudong Wang; Jie Wang B; Yuanfang Guo; Yufeng Tang; Junlian Gu
Journal:  Cell Mol Life Sci       Date:  2021-01-13       Impact factor: 9.261

2.  Hydrogen sulfide ameliorates doxorubicin‑induced myocardial fibrosis in rats via the PI3K/AKT/mTOR pathway.

Authors:  Liangui Nie; Maojun Liu; Jian Chen; Qian Wu; Yaling Li; Jiali Yi; Xia Zheng; Jingjing Zhang; Chun Chu; Jun Yang
Journal:  Mol Med Rep       Date:  2021-03-02       Impact factor: 2.952

Review 3.  The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity.

Authors:  Kerstin N Timm; Damian J Tyler
Journal:  Cardiovasc Drugs Ther       Date:  2020-04       Impact factor: 3.727

4.  MD-1 Deficiency Accelerates Myocardial Inflammation and Apoptosis in Doxorubicin-Induced Cardiotoxicity by Activating the TLR4/MAPKs/Nuclear Factor kappa B (NF-κB) Signaling Pathway.

Authors:  Ying-Jun Zhang; He Huang; Yu Liu; Bin Kong; Guangji Wang
Journal:  Med Sci Monit       Date:  2019-10-22

5.  Identification and Validation of Dilated Cardiomyopathy-Related Genes via Bioinformatics Analysis.

Authors:  Li-Jun Wang; Bai-Quan Qiu; Ming-Ming Yuan; Hua-Xi Zou; Cheng-Wu Gong; Huang Huang; Song-Qing Lai; Ji-Chun Liu
Journal:  Int J Gen Med       Date:  2022-04-05

Review 6.  Autophagy and beyond: Unraveling the complexity of UNC-51-like kinase 1 (ULK1) from biological functions to therapeutic implications.

Authors:  Ling Zou; Minru Liao; Yongqi Zhen; Shiou Zhu; Xiya Chen; Jin Zhang; Yue Hao; Bo Liu
Journal:  Acta Pharm Sin B       Date:  2022-06-11       Impact factor: 14.903

7.  Peptidomics Analysis Reveals Peptide PDCryab1 Inhibits Doxorubicin-Induced Cardiotoxicity.

Authors:  Li Zhang; Xuejun Wang; Mengwen Feng; Hao Zhang; Jia Xu; Jingjing Ding; Zijie Cheng; Lingmei Qian
Journal:  Oxid Med Cell Longev       Date:  2020-10-13       Impact factor: 6.543

8.  Doxorubicin metabolism moderately attributes to putative toxicity in prodigiosin/doxorubicin synergism in vitro cells.

Authors:  Shian-Ren Lin; Chun-Shu Lin; Ching-Cheng Chen; Feng-Jen Tseng; Tsung-Jui Wu; Lebin Weng; Ching-Feng Weng
Journal:  Mol Cell Biochem       Date:  2020-08-04       Impact factor: 3.396

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.